# CVM GFI #64 (VICH  GL2) Validation of Analytical Procedures: Methodology - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-64-vich-gl2-validation-of-analytical-procedures-methodology/11d298b3-90fc-475a-be61-b97fa813f23a

> FDA guidance document: CVM GFI #64 (VICH  GL2) Validation of Analytical Procedures: Methodology. Issue date: August 28, 2024. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #64 (VICH  GL2) Validation of Analytical Procedures: Methodology
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2024-08-28
- Last Changed: 2024-08-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0616">FDA-2021-D-0616</a>

## Related Documents

- [CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-199-animal-generic-drug-user-fees-and-fee-waivers-and-reductions/6fc52a11-514e-4e9d-90b6-c79ef576ec6f)
- [CVM GFI #63 (VICH GL1) Validation of Analytical Procedures: Definition and Terminology](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-63-vich-gl1-validation-of-analytical-procedures-definition-and-terminology/b4b727c0-7b34-4fa8-922a-70806e086f7e)
- [CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-61-special-considerations-incentives-and-programs-to-support-the-approval-of-new-animal-drugs-for-minor-uses-and-for-minor-species/7cbf17f7-6c8b-4e68-9f84-7be2176b22f0)